Filing Details
- Accession Number:
- 0001209191-17-063403
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-04 11:52:32
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-04 11:52:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184746 | N Daniel Gregoire | 55 Nod Road Avon CT 06001 | General Counsel And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2017-12-01 | 3,233 | $63.95 | 16,690 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2017-12-01 | 5,042 | $64.87 | 21,732 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Disposition | 2017-12-01 | 8,275 | $89.08 | 13,457 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2017-12-01 | 3,233 | $0.00 | 3,233 | $63.95 |
Common Stock | Stock Options (right to buy) | Disposition | 2017-12-01 | 5,042 | $0.00 | 5,042 | $64.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,538 | 2025-03-04 | No | 4 | X | Direct | |
10,083 | 2026-03-03 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $88.50 to $90.30, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- The remainder of 12,538 options shall vest on March 4, 2018.
- Not applicable.
- The remainder of 10,083 options shall vest in equal increments on March 3 of 2018 and 2019.